A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

Buch, Stephan, Stickel, Felix, Trépo, Eric, Way, Michael, Herrmann, Alexander, Nischalke, Hans Dieter, Brosch, Mario, Rosendahl, Jonas +40 more·2015·Nature Genetics
DOI 10.1038/ng.3417

Cited by (563)

Items 501–563 of 563

  1. PNPLA3 Variant p.I148M and Bariatric Surgery
    Roman Liebe, Frank Lammert, Marcin Jan Krawczyk · 2016 · Elsevier eBooks
  2. Genetik der nicht-alkoholischen Fettlebererkrankung
    Marcin Jan Krawczyk, Frank Lammert · 2017 · Adipositas - Ursachen Folgeerkrankungen Therapie
  3. A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption
    Flaminia Ferri, Rosellina Margherita Mancina, M. Mischitelli, Alessio Farcomeni, E Poli, Lucia Parlati, Maria Antonella Burza, Adriano De Santis, Claudia Codazzo, Fabio Attilia et al. · 2017 · Journal of Hepatology
  4. Los estudios genéticos y la enfermedad hepática alcohólica
    Pedro Zapater · 2018 · Revista Clínica Española
  5. Cutting-edge topics in the pathophysiology of alcoholic liver disease
    Kenichi Ikejima · 2018 · Kanzo
  6. Genes and NAFLD/NASH Progression
    Rasha El Sharkawy, Jacob George, Mohammed Eslam · 2020 · Springer eBooks
  7. Genetics of Polygenic Metabolic Liver Disease
    Rabea A. Hall, Frank Lammert · 2020 · Elsevier eBooks
  8. Mechanisms of Fibrogenesis in NASH
    Mirella Pastore, Alessandra Gentilini, Fabio Marra · 2020 · Springer eBooks
  9. Nonalcoholic fatty liver disease in relation to cardiovascular disease
    Nynke Simons · 2020
  10. The impact of PNPLA3 and TM6SF2 in cirrhosis related complications
    Xue Shao, Haruki Uojima, Taeang Arai, Yuji Ogawa, Toru Setsu, Masanori Atsukawa, Yoshihiro Furuichi, Yoshitaka Arase, Kazue Horio, Hisashi Hidaka et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the FGF21 locus
    Ali Bayoumi · 2020 · The Sydney eScholarship Repository (The University of Sydney)
  12. Estudio del papel de las rho-quinasas en la respuesta inflamatoria inducida por el alcohol
    Pablo Segovia Alonso · 2020
  13. Clinical, laboratory and molecular-genetic markers of the progression of non-alcoholic fatty liver disease (literature review and own data)
    A.A. Хamrayev, D.H. Yuldasheva · 2021 · Общество и инновации
  14. Association of Common Variant Rs2281135 of PNPLA3 with Alcohol-Related Cirrhosis in Chinese Han Males
    H Chen, Y Zhang, Ju Huang, Fuqiang Yang, Y Zhang, Guo T, Yan Mao, Liu C, Lu Cheng, Yun Li et al. · 2021 · Austin Journal of Pathology & Laboratory Medicine
  15. Influência dos polimorfismos nos genes Patatin-like Phospholipase Domain Containing 3 (PNPLA3) e Transmembrane 6 Superfamily Member 2 (TM6SF2) na hepatite C crônica
    Arthur Ivan Nobre Oliveira · 2021
  16. MODELADO DE LA COMPETICIÓN LINGÜÍSTICA GALLEGO-CASTELLANO: DEFINICIÓN Y OBTENCIÓN DE DISTANCIA INTERLINGÜÍSTICA Y EXTRAPOLACIÓN A FUTURO
    Jorge MIra, Y Ángel Paredes · 2007 · Revista Real Academia Galega de Ciencias
  17. Vulnerability to alcohol‐associated liver disease: A tale of two systems
    Ersin Karataylı, Frank Lammert · 2021 · Hepatology
  18. Alkohol und gastroenterologische Erkrankungen
    Gunda Millonig, Jens Werner, Helmut Karl Seitz · 2020 · Gastroenterologie up2date
  19. Genetic studies and alcoholic liver disease
    P. Zapater · 2018 · Revista Clínica Española (English Edition)
  20. Molecular Basis of Liver Disease
    Satdarshan P. Monga, Jaideep Behari · 2017 · Elsevier eBooks
  21. Membrane Bound O-Acyltransferase 7 (MBOAT7)-Driven Lysophosphatidylinositol (LPI) Acylation in Adipocytes Contributes to Systemic Glucose Homeostasis
    William J. Massey, Venkateshwari Varadharajan, Rakhee Banerjee, Amanda L. Brown, Anthony J. Horak, Rachel C. Hohe, E. Ricky Chan, Calvin Pan, Renliang Zhang, Daniela S. Allende et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Pathophysiologie: Genetik
    Susanne Nicole Weber, Frank Lammert · 2022 · Springer eBooks
  23. Lifestyle and Genetic Modifiers of Liver Disease Progression
    Mattias Mandorfer, Annalisa Berzigotti · 2022 · Springer eBooks
  24. Nonalcoholic fatty liver disease
    Koen C. van Son, Adriaan Georgius Holleboom, Maarten E. Tushuizen · 2023 · Elsevier eBooks
  25. Genetic Variants Determine Treatment Response in Autoimmune Hepatitis
    Stephan Zandanell, Lorenz Balcar, Georg Semmler, Alex Schirmer, Isabella Leitner, Lea Rosenstatter, David Niederseer, Karl Sotlar, Anna-Maria Schneider, Michael Straßer et al. · 2023 · Journal of Personalized Medicine
  26. Liver fibrosis assessed using non-invasive markers and genetic polymorphisms ( PNPLA3 and TM6SF2 ) predisposing to liver fibrosis, is associated with hospitalization or death from heart failure: a prospective UK Biobank study
    Theresa Hydes, Oliver John Kennedy, Kate Glyn‐Owen, Ryan Malcolm Buchanan, Julie Parkes, Daniel James Cuthbertson, Paul J. Roderick, Christopher D. Byrne · 2023 · medRxiv
  27. How can we improve surveillance system for alcohol‐associated hepatocellular carcinoma?
    Kunhee Kim, Hye Won Lee, Sang Hoon Ahn · 2023 · Journal of Gastroenterology and Hepatology
  28. Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1 in HepG2 cells
    Wangfang Hou, Christian Watson, Ted Cecconie, Menaka N. Bolaki, Brady Jennifer J, Quinn Lu, Gregory J. Jr. Gatto, Tovah A. Day · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Molecular pathology of hepatocellular carcinoma
    Juliana Castellano, Arief Antonius Suriawinata · 2023 · Elsevier eBooks
  30. Modulation of Alcohol-Related Liver Disease by Obesity and Diabetes
    Hannes Hegmar, Hannes Hagström · 2023 · Springer eBooks
  31. Alcoholic Fibrosis/Cirrhosis and Its Reversibility
    Massimo Pinzani · 2023 · Springer eBooks
  32. Molecular genetics of neuropsychiatric illness: some musings
    Meghana Janardhanan, Somdatta Sen, Bhagylakshmi Shankarappa, Meera Purushottam · 2023 · Frontiers in Genetics
  33. Membrane Bound O-Acyltransferase 7 (MBOAT7) Shapes Lysosomal Lipid Homeostasis and Function to Control Alcohol-Associated Liver Injury
    Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, Raghav Jain, Rakhee Banerjee, Anthony J. Horak, Megan R. McMullen, Emily Huang, Annette Bellar, Shuhui Wang Lorkowski et al. · 2023 · eLife
  34. Genetic Variation in Angiotensin II Type 1 Receptor Is Linked to Lipid Levels and Hepatic Steatosis in Alcohol-Associated Liver Disease, but Not to Cirrhosis or Hepatocellular Carcinoma
    Hans Dieter Nischalke, Franziska Schmalz, Janett Fischer, Christine Möller, Madlen Matz‐Soja, Benjamin Krämer, Bettina Langhans, Jacob Nattermann, Thomas Berg, Christian P. Strassburg et al. · 2024 · Gastroenterology Insights
  35. Identification of Alcoholic Hepatitis-Related and Mesenchymal Stem Cell Therapy Target Genes
    Seul Ki Han, Taesic Lee, Jisun Lim, Hyunsoo Kim, Young Uh, Moon Young Kim · 2024 · Research Square
  36. Membrane Bound O-Acyltransferase 7 (MBOAT7) Shapes Lysosomal Lipid Homeostasis and Function to Control Alcohol-Associated Liver Injury
    Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, Raghav Jain, Rakhee Banerjee, Anthony J. Horak, Megan R. McMullen, Emily Huang, Annette Bellar, Shuhui Wang Lorkowski et al. · 2024 · eLife
  37. Identification of Alcoholic Hepatitis-related Genes using Liver and Blood Transcriptomes
    Seul Ki Han, Taesic Lee, Jin Suk Lee, Jisun Lim, Hyunsoo Kim, Young Uh, Moon Young Kim · 2024 · Research Square
  38. Liver Steatosis: From Lipotoxicity to Cellular Damage
    Tobias Puengel, Frank Tacke · 2024 · Springer eBooks
  39. Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology
    Helen Ye Rim Huang, Kai Markus Schneider, Carolin Victoria Schneider · 2025 · Seminars in Liver Disease
  40. Impact of differential detection of TM6SF2 rs58542926 mutation in circulating tumor DNA versus peripheral blood cells on hepatocellular carcinoma patients
    Samar Samir Youssef, Eman Abd El Razek Abbas, Mohamed Hassany, Aya Shaaban Ragheb Shaaban, Eman Elsayed Abass Mohammed, Tamer Mahmoud Elbaz · 2025 · Discover Oncology
  41. A partner switch from CDS2 to RAB1A redirects MBOAT7 to inhibit DGAT2-mediated lipid droplet growth
    Jiesi Xu, Jianxin Zhang, Wei Wang, Honggang Su, Siyu Chen, Mei Ding, Xun Huang · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  42. アルコール関連肝疾患について
    一義 今 · 2025 · Nihon Ika Daigaku Igakkai Zasshi
  43. Precision medicine in steatotic liver disease
    Vitchapong Prasitsumrit, Vincent Lingzhi Chen · 2026 · Current Opinion in Gastroenterology
  44. Le microbiote intestinal comme cible thérapeutique dans la maladie alcoolique du foie : implication des acides biliaires et de la pectine
    Dragos Marius Ciocan · 2018 · theses.fr (ABES)
  45. Étude du lien entre maladie alcoolique du foie, microbiote intestinal et acides biliaires : rôles spécifiques de la pectine et du récepteur aux acides biliaires TGR5
    Madeleine Spatz · 2018
  46. Fulminant viral hepatitis in human inherited IL-10RB deficiency
    Cecilia B. Korol · 2020
  47. Modèle de carcinomes hépatocellulaires murins induits par l'expression de l'antigène T SV40 : analyse du transcriptome entier du foie et des variations d'expression ARN liées à l'âge et induites par un régime « occidental »
    Christian Hobeika · 2022 · theses.fr (ABES)
  48. Identification des nouveaux déterminants génétiques prédisposant aux carcinomes hépatocellulaires
    Jie Yang · 2019
  49. Vers une meilleure compréhension de la maladie du foie liée à l'alcool et des facteurs influençant sa progression : approche de modélisation
    Claire Delacôte · 2020
  50. Predictors of metabolic dysfunction-associated steatotic liver diseases (MASLD) in Vietnamese population
    Anh Gia Pham, An Vu-Khanh Le, Yen Thi‐Hai Pham, Lanh Sy Nguyen, Huong Lan Nguyen, Nina Quach, Thau Manh Cao, Hanh Thi Nguyen, Xuan Thanh Thai, Anh Tuan Luong et al. · 2026 · Scientific Reports
  51. Mapping the genomic landscape of MASLD: A framework for molecular subtyping and precision hepatology
    Carlos Jose Pirola, Silvia C. Sookoian · 2026 · Med
  52. Terpenoids in the management of MASLD: Multi-target mechanisms, therapeutic potential, and future perspectives
    Chengzi Huang, Rong Zhang, Caizhi Liu, Cheng Hu · 2026 · Pharmacological Research
  53. The association of non-alcoholic fatty liver index, plasma metal levels, and genetic susceptibility using genome-wide type analysis
    Su-Hsuan Yu, Kuei‐Hau Luo, C S Yang, Chia‐Yen Dai, Hung‐Yi Chuang · 2026 · Journal of Trace Elements in Medicine and Biology
  54. Reverse Mendelian randomisation analysis of the causal effect of body mass index on cirrhosis risk: a large-scale genetic study
    Feifei Liu, Xiaotong Du, Huan Wang, Qi Feng, Shuang Liang, Jiangman Song, Xiaojing Lian · 2026 · Critical Public Health
  55. High incidence of advanced liver disease and mortality in patients presenting with alcohol use disorder
    Amir Gougol, Dhiraj Yadav, Robert Feldman, Andrew D. Althouse, Melissa Saul, Ana Clemente-Sánchez, Gavin E. Arteel, Ramon A. Bataller · 2026 · Hepatology Communications
  56. Gene–environment interaction between heavy alcohol use and PNPLA3 rs738409 in incident cirrhosis: Evidence from a diverse U.S. cohort
    Krushi B. Suresh, Ronak Bhatia, Muhammad Sajawal, Oliver Sabet, Iman Zahedi, Agasou Rameau, Ayomidipupo Fadaka, Wardah Bajwa, Muhammad Bilal Shahid, Shaheen Alvi et al. · 2026 · Clinics and Research in Hepatology and Gastroenterology
  57. Alcohol-related liver disease and access to liver transplantation: where we stand and where we should go
    Inês Mega, Eloisa Franchi, Giacomo Germani, Hermien Hartog, Speranța Iacob, Philippe Mathurin, Silvio Nadalin, Stephen G. Potts, Giuliano Testa, Luca Saverio Belli · 2026 · Transplant International
  58. Waist-to-height ratio as a practical indicator for screening pediatric metabolic dysfunction-associated steatotic liver disease in diverse populations and genetic backgrounds
    Yunfei Liu, You-Xin Wang, Li Li, Di Shi, Maike Wolters, Ping-Ping Zhang, Jia-Jia Dang, Shan Cai, Tian-Yu Huang, Yaqi Wang et al. · 2026 · World Journal of Pediatrics
  59. Genome-wide association studies to identify shared and distinct mechanisms of fibrosis across 12 organ systems
    Ebrima Joof, Tamara Hernández-Beeftink, Gina Parcesepe, Georgie May Massen, Ritah Nabunje, Hayley J Power, Ruby M Woodward, Feras Altunusi, Olivia C. Leavy, Hilary J Longhurst et al. · 2026 · BMJ connections.
  60. Multi-Omics and Its Clinical Application in Hepatocellular Carcinoma: Current Progress and Future Opportunities
    Wanshui Yang, Jiang Hanyu, Chao Liu, Jingwei Wei, Yu Zhou, Pengyun Gong, Bin Song, Tian Jie · 2021 · Chinese Medical Sciences Journal
  61. PNPLA3 and TM6SF2 gene polymorphisms in predicting alcoholic liver cirrhosis: analysis of synergistic effects
    О. S. Pershenkova · 2026 · Health and Ecology Issues
  62. Predicting response to GLP-1–based therapy in MASLD/MASH: an evidence-tiered, endpoint-specific framework built on host genotype and gut microbial features
    Guojian Zhu, Yucao Huang, Yun Huang, 杨文龙 · 2026 · Frontiers in Endocrinology
  63. Molecular Pathogenesis and Risk Factors Underlying ALD
    Devanshi Seth, Tarun Murali · 2026 · Springer eBooks